News

According to new data, NeuroStar Advanced TMS helped nearly 60% of adolescents with major depressive disorder.

Fill out this survey if you are a clinician who lactated while working.

Is it healthy to cut off family and friends due to political differences?

Check out new results of a pharmacokinetics study of AD04, an investigational therapeutic agent for the treatment of alcohol use disorder in patients with heavy drinking.

It's time for kindness...

ADHD doubles the rates of all-cause mortality. How can you best help patients?

Let’s explore the barriers and current evidence on mental health care access for foster children.

Here's why early career clinicians should engage with critical psychiatry.

"After each lap around the circular hall the aides smile, Hello Doctor!"

The FDA has granted clearance to the Horizon Inspire transcranial magnetic stimulation system to treat major depressive disorder, obsessive-compulsive disorder, and anxious depression.

Awais Aftab, MD, shares more on his upcoming book.

Traumatic life events are common among individuals who experience psychosis. Here's how best to assess and treat.

How can you distinguish bipolar mixed states? Stay tuned in this short series.

Are you attending Real Psychiatry in January?

“Only the shallow know themselves.”

There is an accumulating body of evidence that metformin may have benefits in aging beyond its effect on glycemic control.

Hope for veterans on this Veterans Day.

Emraclidine once-daily, oral monotherapy treatment for adults with schizophrenia experiencing acute psychotic symptoms, failed to meet the primary endpoints in the 2 phase 2 EMPOWER trials.

Adultd ADHD: What are the best practices and how do we apply the science? An expert weighs in.

Patients who have experienced a perinatal loss are at increased risk of MDD, anxiety disorders, and trauma-related disorders.

This article explains the role of medications that have high affinity to block dopamine D4.

"The national day had dawned."

“People in glass houses shouldn’t throw stones.”

The medication treatment of schizophrenia has finally diversified to a novel neurotransmitter system: the muscarinic cholinergic system.

While still following the Goldwater Rule, how can psychiatrists help improve mental health following the election?

How can psychiatric clinicians help their patients (and themselves) identify and navigate the aftermath of the election?

We need psychiatrists now more than ever...

New positive results demonstrate the efficacy and safety of lumateperone (Caplyta) 42 mg for the prevention of relapse in adult patients with schizophrenia.

How can we ensure an accountable, effective, and limited conservatorship system? Here are some actionable concepts.